These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1546303)

  • 1. Alzheimer's assault.
    Science; 1992 Feb; 255(5048):1059. PubMed ID: 1546303
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease. Short precursor shortens memory.
    Mattson MP; Furukawa K
    Nature; 1997 May; 387(6632):457-8. PubMed ID: 9168104
    [No Abstract]   [Full Text] [Related]  

  • 3. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
    Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW
    Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Alzheimer's disease in transgenic mice.
    Duff K
    J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model mice. Transgenic animals and Alzheimer's research.
    Erickson D
    Sci Am; 1991 Sep; 265(3):34. PubMed ID: 1925493
    [No Abstract]   [Full Text] [Related]  

  • 7. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: Abeta, tau and synaptic dysfunction.
    LaFerla FM; Oddo S
    Trends Mol Med; 2005 Apr; 11(4):170-6. PubMed ID: 15823755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homocysteine levels are not increased in murine models of Alzheimer's disease.
    Santiard-Baron D; Aupetit J; Janel N
    Neurosci Res; 2005 Dec; 53(4):447-9. PubMed ID: 16213620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.
    Götz J; Streffer JR; David D; Schild A; Hoerndli F; Pennanen L; Kurosinski P; Chen F
    Mol Psychiatry; 2004 Jul; 9(7):664-83. PubMed ID: 15052274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mouse models of Alzheimer's disease: phenotype and application.
    Higgins GA; Jacobsen H
    Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mouse and chemical lesion approaches to the study of Alzheimer's disease.
    Tang F; Li H; Nag S; Xu G; Chan T
    Chin Med J (Engl); 1997 Aug; 110(8):642-7. PubMed ID: 9594272
    [No Abstract]   [Full Text] [Related]  

  • 13. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
    Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
    Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease.
    Ognibene E; Middei S; Daniele S; Adriani W; Ghirardi O; Caprioli A; Laviola G
    Behav Brain Res; 2005 Jan; 156(2):225-32. PubMed ID: 15582108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease.
    Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR
    Brain Res Bull; 2005 Apr; 65(4):317-22. PubMed ID: 15811597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesions and genes: on the edge of improved isomorphic models for Alzheimer's disease?
    Gonzalez de Aguilar JL; Loeffler JP; Boutillier AL
    Neurodegener Dis; 2008; 5(5):318-20. PubMed ID: 18520166
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models.
    Brendza RP; Bales KR; Paul SM; Holtzman DM
    Mol Psychiatry; 2002; 7(2):132-5. PubMed ID: 11840304
    [No Abstract]   [Full Text] [Related]  

  • 19. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steps towards a mouse model of Alzheimer's disease.
    Crowther RA
    Bioessays; 1995 Jul; 17(7):593-5. PubMed ID: 7646481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.